Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1085


Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Church T, Yurgalevitch S, Austin JH, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Jul 6;97(13):989-97.


Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL, Schoen RE, Pinsky PF, Bresalier RS, Doria-Rose VP, Laiyemo AO, Church T, Yokochi LA, Yurgalevitch S, Rathmell J, Andriole GL, Buys S, Crawford ED, Fouad M, Isaacs C, Lamerato L, Reding D, Prorok PC, Berg CD; PLCO Project Team.

J Natl Cancer Inst. 2012 Feb 22;104(4):280-9. doi: 10.1093/jnci/djr549. Epub 2012 Jan 31.


Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.

Segnan N, Senore C, Andreoni B, Arrigoni A, Bisanti L, Cardelli A, Castiglione G, Crosta C, DiPlacido R, Ferrari A, Ferraris R, Ferrero F, Fracchia M, Gasperoni S, Malfitana G, Recchia S, Risio M, Rizzetto M, Saracco G, Spandre M, Turco D, Turco P, Zappa M; SCORE2 Working Group-Italy.

J Natl Cancer Inst. 2005 Mar 2;97(5):347-57.


Variability in flexible sigmoidoscopy performance among examiners in a screening trial.

Pinsky PF, Schoen RE, Weissfeld JL, Kramer B, Hayes RB, Yokochi L; PLCO Project Team.

Clin Gastroenterol Hepatol. 2005 Aug;3(8):792-7.


Female gender and other factors predictive of a limited screening flexible sigmoidoscopy examination for colorectal cancer.

Eloubeidi MA, Wallace MB, Desmond R, Farraye FA.

Am J Gastroenterol. 2003 Jul;98(7):1634-9.


Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Weissfeld JL, Ling BS, Schoen RE, Bresalier RS, Riley T, Prorok PC; Prostate, Lung, Colorectal, and Ovarian Project Team.

Cancer. 2002 May 15;94(10):2569-76.


Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.

Schoen RE, Weissfeld JL, Pinsky PF, Riley T.

Gastroenterology. 2006 Dec;131(6):1683-9. Epub 2006 Aug 14.


Inter-endoscopist variation in polyp and neoplasia pick-up rates in flexible sigmoidoscopy screening for colorectal cancer.

Bretthauer M, Skovlund E, Grotmol T, Thiis-Evensen E, Gondal G, Huppertz-Hauss G, Efskind P, Hofstad B, Thorp Holmsen S, Eide TJ, Hoff G.

Scand J Gastroenterol. 2003 Dec;38(12):1268-74.


Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Oken MM, Marcus PM, Hu P, Beck TM, Hocking W, Kvale PA, Cordes J, Riley TL, Winslow SD, Peace S, Levin DL, Prorok PC, Gohagan JK; PLCO Project Team.

J Natl Cancer Inst. 2005 Dec 21;97(24):1832-9.


Significance of distal polyps detected with flexible sigmoidoscopy in asymptomatic patients.

Matter SE, Campbell DR.

Arch Intern Med. 1992 Sep;152(9):1776-80.


Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study.

Flood A, Peters U, Jenkins DJ, Chatterjee N, Subar AF, Church TR, Bresalier R, Weissfeld JL, Hayes RB, Schatzkin A; Prostate, Lung, Colorectal, Ovarian (PLCO) Project Team.

Am J Clin Nutr. 2006 Nov;84(5):1184-92.


Screening for colorectal cancer with fecal occult blood testing and sigmoidoscopy.

Winawer SJ, Flehinger BJ, Schottenfeld D, Miller DG.

J Natl Cancer Inst. 1993 Aug 18;85(16):1311-8.


The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial of the National Cancer Institute: history, organization, and status.

Gohagan JK, Prorok PC, Hayes RB, Kramer BS; Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team.

Control Clin Trials. 2000 Dec;21(6 Suppl):251S-272S.


Efficacy of screening flexible sigmoidoscopy for colorectal neoplasia in asymptomatic subjects.

Gupta TP, Jaszewski R, Luk GD.

Am J Med. 1989 May;86(5):547-50.


Screening for colorectal cancer: randomised trial comparing guaiac-based and immunochemical faecal occult blood testing and flexible sigmoidoscopy.

Hol L, van Leerdam ME, van Ballegooijen M, van Vuuren AJ, van Dekken H, Reijerink JC, van der Togt AC, Habbema JD, Kuipers EJ.

Gut. 2010 Jan;59(1):62-8. doi: 10.1136/gut.2009.177089. Epub .


Risks, costs, and compliance limit colorectal adenoma surveillance: lessons from a randomised trial.

Lund JN, Scholefield JH, Grainge MJ, Smith SJ, Mangham C, Armitage NC, Robinson MH, Logan RF.

Gut. 2001 Jul;49(1):91-6.


The Norwegian Colorectal Cancer Prevention (NORCCAP) screening study: baseline findings and implementations for clinical work-up in age groups 50-64 years.

Gondal G, Grotmol T, Hofstad B, Bretthauer M, Eide TJ, Hoff G.

Scand J Gastroenterol. 2003 Jun;38(6):635-42.


Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.

Laiyemo AO, Doubeni C, Pinsky PF, Doria-Rose VP, Bresalier R, Lamerato LE, Crawford ED, Kvale P, Fouad M, Hickey T, Riley T, Weissfeld J, Schoen RE, Marcus PM, Prorok PC, Berg CD.

J Natl Cancer Inst. 2010 Apr 21;102(8):538-46. doi: 10.1093/jnci/djq068. Epub 2010 Mar 31.


One-time screening for colorectal cancer with combined fecal occult-blood testing and examination of the distal colon.

Lieberman DA, Weiss DG; Veterans Affairs Cooperative Study Group 380.

N Engl J Med. 2001 Aug 23;345(8):555-60.

Items per page

Supplemental Content

Write to the Help Desk